Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LDL-hypercholesterolemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00249938
What this trial is testing

Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol.

Who this might be right for
HyperlipidemiaDyslipidemia
University of Colorado, Denver 60
Not applicableStudy completedNCT04148001
What this trial is testing

Identifying and Genotyping Homozygous Familial Hypercholesterolemia (HoFH) Patients

Who this might be right for
Homozygous Familial Hypercholesterolemia (HoFH)
REGENXBIO Inc. 4
Large-scale testing (Phase 3)Study completedNCT00239330
What this trial is testing

Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy

Who this might be right for
Hypercholesteremia
AstraZeneca 824
Post-approval studies (Phase 4)Study completedNCT00762164
What this trial is testing

Comparison of the Effect of Vytorin 10/80 Tablet Split Into 4 and Simvastatin 20 Milligrams on Low-density Lipoprotein (LDL) Cholesterol

Who this might be right for
Hypercholesterolemia
Bronx VA Medical Center 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07839936
What this trial is testing

VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular Disease

Who this might be right for
AtherosclerosisCardiovascular DiseaseHypercholesterolemia
Verve Therapeutics, Inc. 175
Not applicableStudy completedNCT00526721
What this trial is testing

Real-life EValuation Of High Dose RosUvastatin in High Risk Patients After TitraTION

Who this might be right for
Hypercholesterolemia
AstraZeneca 1,482
Not applicableStudy completedNCT05750602
What this trial is testing

Combined Effect of LIMICOL and Physical Activity on LDL Cholesterol and Muscle Function.

Who this might be right for
Hypercholesterolemia
Lescuyer Laboratory 40
Large-scale testing (Phase 3)Study completedNCT04873934
What this trial is testing

Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome
Novartis Pharmaceuticals 400
Large-scale testing (Phase 3)Study completedNCT03400800
What this trial is testing

Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol

Who this might be right for
ASCVDRisk Factor, CardiovascularElevated Cholesterol
The Medicines Company 1,617
Large-scale testing (Phase 3)Study completedNCT00653744
What this trial is testing

Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)

Who this might be right for
HypercholesterolemiaDyslipidaemia
AstraZeneca 1,700
Early research (Phase 1)Not Yet RecruitingNCT07074236
What this trial is testing

Pharmacokinetics and Pharmacodynamics Study

Who this might be right for
Primary Hypercholesterolemia or Combined Hyperlipidemia Characterized by Elevated LDL-C
Qilu Pharmaceutical Co., Ltd. 48
Large-scale testing (Phase 3)Study completedNCT00150371
What this trial is testing

Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration

Who this might be right for
Hypercholesterolemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1,100
Not applicableStudy completedNCT01610609
What this trial is testing

Reducing Disparities in Primary Prevention of Cardiovascular Disease

Who this might be right for
Cardiovascular DiseasesCholesterol, LDL
Northwestern University 646
Large-scale testing (Phase 3)UnknownNCT04806893
What this trial is testing

Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction

Who this might be right for
Cardiovascular Risk FactorCardiovascular DiseasesCardiovascular Stroke+1 more
LIB Therapeutics LLC 900
Testing effectiveness (Phase 2)Study completedNCT01380730
What this trial is testing

LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy

Who this might be right for
Hyperlipidemia
Amgen 631
Not applicableStudy completedNCT01562171
What this trial is testing

Lentils as a Functional Food to Improve Glucose and Decrease Cardiovascular Risk

Who this might be right for
ObesityHypercholesterolemia
University of Manitoba 102
Testing effectiveness (Phase 2)Study completedNCT00404001
What this trial is testing

Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
Ironwood Pharmaceuticals, Inc. 150
Very early researchStudy completedNCT00863265
What this trial is testing

Phytosterols, Ezetimibe, and Cholesterol Metabolism

Who this might be right for
HypercholesterolemiaCoronary Heart Disease
Washington University School of Medicine 22
Large-scale testing (Phase 3)Study completedNCT00092599
What this trial is testing

Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)

Who this might be right for
HypercholesterolemiaCoronary Disease
Organon and Co 410
Post-approval studies (Phase 4)Active Not RecruitingNCT07442630
What this trial is testing

Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides

Who this might be right for
Hypercholesterolemia
JW Pharmaceutical 88
Next Page